Pharmaceuticals

AstraZeneca

A UK-headquartered biopharmaceutical company with a drug portfolio spanning oncology, cardiovascular, respiratory and rare-disease treatments.

Ticker: AZNNYSE-listedUnited Kingdom
Market chart

AstraZeneca stock chart

Change the time range to compare recent moves with longer trends. Chart data is provided by TradingView.

What is AstraZeneca?

AstraZeneca, based in Cambridge, UK, is a biopharmaceutical company focused on discovering, developing and commercializing prescription medicines. Its portfolio spans oncology, cardiovascular and renal disease, respiratory and immunology, and rare diseases.

Why investors watch AstraZeneca

AstraZeneca has built a substantial oncology drug portfolio and a globally diversified sales base across many countries. Investors often follow its clinical pipeline and drug approvals as key drivers of future growth alongside its existing product portfolio.

Risks and volatility

Pharmaceutical companies face patent expirations, known as patent cliffs, that can significantly reduce revenue from a drug once generic competition is allowed to enter. Clinical trial failures, regulatory approval risk, and drug-pricing policy — particularly in the US — are also ongoing risks for the sector.

Long-term investing considerations

A pharmaceutical company's growth often depends on a pipeline of future drug approvals that is inherently uncertain. When modeling long-term scenarios, avoid assuming any single drug's success will continue indefinitely.

Company snapshot

Company profile

A quick reference snapshot — sector, description and key stats, provided by TradingView.

Fundamentals

Key financials

Revenue, margins and other reported financial data, provided by TradingView. Figures reflect company filings and can change as new reports are released.